The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapy
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 27, Issue 9, Pages 1696-1705
Publisher
Oxford University Press (OUP)
Online
2016-06-23
DOI
10.1093/annonc/mdw242
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Suggested Approach to Simplify and Improve Cervical Screening in the United States
- (2016) Mark Schiffman et al. Journal of Lower Genital Tract Disease
- Squamous Cell Carcinoma of the Vulva
- (2015) Fei Dong et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Genetic and epigenetic changes in vulvar squamous cell carcinoma and its precursor lesions: A review of the current literature
- (2015) Marjolijn D. Trietsch et al. GYNECOLOGIC ONCOLOGY
- Global availability of data on HPV genotype-distribution in cervical, vulvar and vaginal disease and genotype-specific prevalence and incidence of HPV infection in females
- (2015) Monika Wagner et al. Infectious Agents and Cancer
- Improved Clearance during Treatment of HPV-Positive Head and Neck Cancer through mTOR Inhibition
- (2015) Joseph D. Coppock et al. NEOPLASIA
- Genetic and epigenetic variation in vulvar cancer: Current research and future clinical practice
- (2014) Rebekah E. McWhirter et al. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY
- CDKN2A(p16) and HRAS are frequently mutated in vulvar squamous cell carcinoma
- (2014) Marjolijn D. Trietsch et al. GYNECOLOGIC ONCOLOGY
- MEK1/2 inhibitors in the treatment of gynecologic malignancies
- (2014) Caela R. Miller et al. GYNECOLOGIC ONCOLOGY
- mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: A critical review
- (2014) Nader Husseinzadeh et al. GYNECOLOGIC ONCOLOGY
- Improved Survival with Bevacizumab in Advanced Cervical Cancer
- (2014) Krishnansu S. Tewari et al. NEW ENGLAND JOURNAL OF MEDICINE
- Designing a High-Throughput Somatic Mutation Profiling Panel Specifically for Gynaecological Cancers
- (2014) Vivian M. Spaans et al. PLoS One
- Cyclin-Dependent Kinase Modulators and Cancer Therapy
- (2013) Marialucia Gallorini et al. BIODRUGS
- Temsirolimus in Daily Use: Results of a Prospective Multicentre Noninterventional Study of Patients with Metastatic Kidney Cancer
- (2013) Andres Jan Schrader et al. EUROPEAN UROLOGY
- Etiology of vulvar cancer will impact on treatment options and therapy outcome: Two major pathways of vulvar cancer
- (2013) Sigrid Regauer et al. GYNECOLOGIC ONCOLOGY
- Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers
- (2013) Charles A. Kunos et al. GYNECOLOGIC ONCOLOGY
- Identification of oropharyngeal squamous cell carcinomas with active HPV16 involvement by immunohistochemical analysis of the retinoblastoma protein pathway
- (2013) Dana Holzinger et al. INTERNATIONAL JOURNAL OF CANCER
- Genetic variation in the TLR and NF-κB pathways and cervical and vulvar cancer risk: A population-based case-control study
- (2013) Clara Bodelon et al. INTERNATIONAL JOURNAL OF CANCER
- Biomarkers for Anti-Angiogenic Therapy in Cancer
- (2013) Markus Wehland et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- RB1 in cancer: Different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesis
- (2013) Riccardo Di Fiore et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Fascin and cyclin D1 immunoreactivity in non-neoplastic vulvar squamous epithelium, vulvar intraepithelial neoplasia and invasive squamous carcinoma: correlation with Ki67 and p16 protein expression
- (2013) C J R Stewart et al. JOURNAL OF CLINICAL PATHOLOGY
- Emerging drug profile: cyclin-dependent kinase inhibitors
- (2013) James S. Blachly et al. LEUKEMIA & LYMPHOMA
- Molecular mechanisms underlying RB protein function
- (2013) Frederick A. Dick et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Cell cycle-regulatory cyclins and their deregulation in oral cancer
- (2013) Rajakishore Mishra ORAL ONCOLOGY
- Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva
- (2012) N.S. Horowitz et al. GYNECOLOGIC ONCOLOGY
- Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma
- (2012) Marta del Pino et al. HISTOPATHOLOGY
- Role of cyclin D1 amplification and expression in vulvar carcinomas
- (2012) Matthias Choschzick et al. HUMAN PATHOLOGY
- PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies HarboringPIK3CAMutations
- (2012) Filip Janku et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic significance of c-KIT in vulvar cancer: bringing this molecular marker from bench to bedside
- (2012) Beatriz de Melo Maia et al. Journal of Translational Medicine
- Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study
- (2012) Isabelle Ray-Coquard et al. LANCET ONCOLOGY
- Global Burden of Human Papillomavirus and Related Diseases
- (2012) David Forman et al. VACCINE
- Therapy of Human Papillomavirus-Related Disease
- (2012) Peter L. Stern et al. VACCINE
- A phase I pharmacokinetic and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors
- (2011) D. Mahadevan et al. ANNALS OF ONCOLOGY
- Combining molecular targeted therapies
- (2011) Xavier Pivot et al. ANTI-CANCER DRUGS
- Expression pattern of class I histone deacetylases in vulvar intraepithelial neoplasia and vulvar cancer: a tissue microarray study
- (2011) Nicolas Samartzis et al. BMC CANCER
- A first in man, phase I dose-escalation study of PHA-793887, an inhibitor of multiple cyclin-dependent kinases (CDK2, 1 and 4) reveals unexpected hepatotoxicity in patients with solid tumors
- (2011) Christophe Massard et al. CELL CYCLE
- Vascular Endothelial Growth Factor-Targeted Therapy for the Treatment of Renal Cell Carcinoma
- (2011) Bernard Escudier et al. DRUGS
- A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia
- (2011) H.J. Mackay et al. GYNECOLOGIC ONCOLOGY
- Promising molecular targeted therapies in breast cancer
- (2011) Radha Munagala et al. INDIAN JOURNAL OF PHARMACOLOGY
- Role of TP53 Mutations in Vulvar Carcinomas
- (2011) Matthias Choschzick et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group
- (2011) Amit M. Oza et al. JOURNAL OF CLINICAL ONCOLOGY
- Human Papillomaviruses As Therapeutic Targets in Human Cancer
- (2011) Karin Hellner et al. JOURNAL OF CLINICAL ONCOLOGY
- EGFRgene copy number increase in vulvar carcinomas is linked with poor clinical outcome
- (2011) L Woelber et al. JOURNAL OF CLINICAL PATHOLOGY
- Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study
- (2011) Walter H Gotlieb et al. LANCET ONCOLOGY
- Optimization of 6,6-dimethyl pyrrolo[3,4-c]pyrazoles: Identification of PHA-793887, a potent CDK inhibitor suitable for intravenous dosing
- (2010) Maria Gabriella Brasca et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Phase I Trial of Pelvic Radiation, Weekly Cisplatin, and 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, NSC #663249) for Locally Advanced Cervical Cancer
- (2010) C. A. Kunos et al. CLINICAL CANCER RESEARCH
- Association between toll-like receptor expression and human papillomavirus type 16 persistence
- (2010) Ibrahim I. Daud et al. INTERNATIONAL JOURNAL OF CANCER
- "Differentiated-Type Vulval Intraepithelial Neoplasia Has a High-Risk Association With Vulval Squamous Cell Carcinoma"
- (2010) Hedwig P. van de Nieuwenhof et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- HPV-related Carcinogenesis: Basic Concepts, Viral Types and Variants
- (2009) Marcela Lizano et al. ARCHIVES OF MEDICAL RESEARCH
- SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples
- (2009) Andrew Conroy et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A review of molecular pathological markers in vulvar carcinoma: lack of application in clinical practice
- (2009) S Knopp et al. JOURNAL OF CLINICAL PATHOLOGY
- Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
- (2009) Gemma G. Kenter et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Role of EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer
- (2009) M. Ray et al. ONCOLOGIST
- Decreased survival in EGFR gene amplified vulvar carcinoma
- (2008) Whitfield B. Growdon et al. GYNECOLOGIC ONCOLOGY
- Recurrent metastatic vulvar carcinoma treated with cisplatin plus cetuximab
- (2007) S.D. RICHARD et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started